Home LiteratureArticle Details
PMID: 17215365 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Biomimetic amplification of nanoparticle homing to tumors.

Simberg D, Duza T, Park JH, Essler M, Pilch J, Zhang L, Derfus AM, Yang M, Hoffman RM, Bhatia S, Sailor MJ, Ruoslahti E

Abstract

Nanoparticle-based diagnostics and therapeutics hold great promise because multiple functions can be built into the particles. One such function is an ability to home to specific sites in the body. We describe here biomimetic particles that not only home to tumors, but also amplify their own homing. The system is based on a peptide that recognizes clotted plasma proteins and selectively homes to tumors, where it binds to vessel walls and tumor stroma. Iron oxide nanoparticles and liposomes coated with this tumor-homing peptide accumulate in tumor vessels, where they induce additional local clotting, thereby producing new binding sites for more particles. The system mimics platelets, which also circulate freely but accumulate at a diseased site and amplify their own accumulation at that site. The self-amplifying homing is a novel function for nanoparticles. The clotting-based amplification greatly enhances tumor imaging, and the addition of a drug carrier function to the particles is envisioned.

MeSH Terms
Amino Acid Sequence Animals Biomimetics/methods Cell Line, Tumor Liver/drug effects Mice Mice, Transgenic Nanoparticles/chemistry Neoplasms/blood supply,diagnosis Neovascularization, Pathologic Peptides/chemistry,pharmacology Thrombosis/chemically induced,pathology
Chemicals
Peptides
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Simberg Dmitri
Cancer Research Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Duza Tasmia
Park Ji Ho
Essler Markus
Pilch Jan
Zhang Lianglin
Derfus Austin M
Yang Meng
Hoffman Robert M
Bhatia Sangeeta
Sailor Michael J
Ruoslahti Erkki
References (32)
32 references, click to expand
  1. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy.
    Nature. 2004 Jun 10;429(6992):629-35 PMID: 15190345
  2. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes.
    Biomaterials. 2004 Nov;25(26):5681-703 PMID: 15147815
  3. The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes.
    Biochim Biophys Acta. 1981 May 18;674(3):354-71 PMID: 6165399
  4. Regulation of extravascular coagulation by microvascular permeability.
    Science. 1985 Mar 1;227(4690):1059-61 PMID: 3975602
  5. Superparamagnetic iron oxide: pharmacokinetics and toxicity.
    AJR Am J Roentgenol. 1989 Jan;152(1):167-73 PMID: 2783272
  6. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.
    Cancer Res. 1990 Aug 1;50(15):4478-84 PMID: 2369726
  7. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.
    J Immunol Methods. 1994 Sep 14;174(1-2):83-93 PMID: 8083541
  8. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.
    Genes Dev. 1995 Aug 15;9(16):2020-33 PMID: 7649481
  9. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
    Magn Reson Imaging. 1995;13(5):661-74 PMID: 8569441
  10. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
    Magn Reson Imaging. 1995;13(5):675-91 PMID: 8569442
  11. Organ targeting in vivo using phage display peptide libraries.
    Nature. 1996 Mar 28;380(6572):364-6 PMID: 8598934
  12. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice.
    J Biomed Mater Res. 1996 Jul;31(3):401-8 PMID: 8806067
  13. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature.
    Science. 1997 Jan 24;275(5299):547-50 PMID: 8999802
  14. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages.
    J Magn Reson Imaging. 1997 Nov-Dec;7(6):1140-5 PMID: 9400860
  15. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor.
    Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8663-8 PMID: 10411932
  16. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
    Biomed Microdevices. 2004 Dec;6(4):297-309 PMID: 15548877
  17. Platelet depletion by anti-CD41 (alphaIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines.
    Blood. 2005 Mar 1;105(5):1956-63 PMID: 15494426
  18. The MET oncogene drives a genetic programme linking cancer to haemostasis.
    Nature. 2005 Mar 17;434(7031):396-400 PMID: 15772665
  19. Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.
    Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7087s-7092s PMID: 16203807
  20. A selective tumor microvasculature thrombogen that targets a novel receptor complex in the tumor angiogenic microenvironment.
    Cancer Res. 2005 Dec 1;65(23):11109-17 PMID: 16322261
  21. Nanoparticle-induced platelet aggregation and vascular thrombosis.
    Br J Pharmacol. 2005 Nov;146(6):882-93 PMID: 16158070
  22. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
    Clin Cancer Res. 2006 Feb 15;12(4):1317-24 PMID: 16489089
  23. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.
    Nano Lett. 2006 Apr;6(4):669-76 PMID: 16608262
  24. Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.
    Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2800-4 PMID: 16476999
  25. Transgenic mouse models of human breast cancer.
    Oncogene. 2000 Dec 11;19(53):6130-7 PMID: 11156526
  26. Long-circulating and target-specific nanoparticles: theory to practice.
    Pharmacol Rev. 2001 Jun;53(2):283-318 PMID: 11356986
  27. A tumor-homing peptide with a targeting specificity related to lymphatic vessels.
    Nat Med. 2002 Jul;8(7):751-5 PMID: 12053175
  28. Nanocrystal targeting in vivo.
    Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12617-21 PMID: 12235356
  29. Specialization of tumour vasculature.
    Nat Rev Cancer. 2002 Feb;2(2):83-90 PMID: 12635171
  30. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.
    Cancer Cell. 2003 Nov;4(5):383-91 PMID: 14667505
  31. Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo.
    Circulation. 2004 Mar 16;109(10):1320-5 PMID: 15007013
  32. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.
    Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9381-6 PMID: 15197262
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2007-01-16
Epub
2007-00-10
Pages
932-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC1783417
Subset
IM
Grants
NCI NIH HHS · U54 CA119335 · United States
NCI NIH HHS · R44 CA099258 · United States
NCI NIH HHS · N01 CO 37117 · United States
NCI NIH HHS · R43 CA099258 · United States
NCI NIH HHS · CA 119335 · United States
NCI NIH HHS · CA 099258 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com